BiotechTube
Home/Prolifagen Therapeutics/Claudine Bruck
CB

Claudine Bruck

Co-Founder & Board Chair

Prolifagen Therapeutics

Therapeutic Areas

Cardiovascular DiseaseMyocardial Infarction

Prolifagen Therapeutics Pipeline

DrugIndicationPhase
PRO302Heart muscle regeneration post-myocardial infarctionPreclinical

Leadership Team at Prolifagen Therapeutics

MB
Mike Behr
Chief Executive Officer
KS
Kiernan Seth
Chief Development Officer
WH
Will Houston
Chief Financial Officer
AB
Andreas Bader
Consultant Chief Science Officer
View full Prolifagen Therapeutics profile